Campbell Co Investment Adviser buys $410,431 stake in Innospec (IOSP)

Innospec (IOSP) : Campbell Co Investment Adviser scooped up 3,259 additional shares in Innospec during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 2, 2016. The investment management firm now holds a total of 8,459 shares of Innospec which is valued at $410,431.Innospec makes up approximately 1.50% of Campbell Co Investment Adviser’s portfolio.

Innospec closed down -0.36 points or -0.74% at $48.52 with 1,80,307 shares getting traded on Friday. Post opening the session at $48.62, the shares hit an intraday low of $48.22 and an intraday high of $49.15 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

Other Hedge Funds, Including , Wedbush Securities Inc reduced its stake in IOSP by selling 97 shares or 1.47% in the most recent quarter. The Hedge Fund company now holds 6,485 shares of IOSP which is valued at $314,652. Innospec makes up approx 0.06% of Wedbush Securities Inc’s portfolio.Russell Frank Co reduced its stake in IOSP by selling 10,091 shares or 20.94% in the most recent quarter. The Hedge Fund company now holds 38,092 shares of IOSP which is valued at $1,842,129. Aperio Group sold out all of its stake in IOSP during the most recent quarter. The investment firm sold 4,116 shares of IOSP which is valued $199,050.Metlife Securities Inc reduced its stake in IOSP by selling 62 shares or 67.39% in the most recent quarter. The Hedge Fund company now holds 30 shares of IOSP which is valued at $1,467.

On the company’s financial health, Innospec reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.12 according to the earnings call on May 3, 2016. Analyst had a consensus of $0.81. The company had revenue of $212.10 million for the quarter, compared to analysts expectations of $252.15 million. The company’s revenue was down -21.2 % compared to the same quarter last year.

Many Wall Street Analysts have commented on Innospec. Innospec was Upgraded by KeyBanc Capital Mkts to ” Overweight” on Apr 5, 2016.

Innospec Inc. develops manufactures blends markets and supplies fuel additives oilfield chemicals personal care and fragrance ingredients and other specialty chemicals. The Company’s products are sold primarily to oil and gas exploration and production companies oil refineries personal care and fragrance companies and other chemical and industrial companies. Its fuel additives improve fuel efficiency boost engine performance and reduce harmful emissions. Its oilfield specialties business supplies drilling and production chemicals for exploration and production. Its other specialty chemicals provide technology-based solutions for its customers’ processes or products focused in the Personal Care Polymers and Fragrance Ingredients markets. Its Octane Additives business manufactures products for use in automotive gasoline and provides services in the environmental remediation. The Company has three business segments: Fuel Specialties Performance Chemicals and Octane Additives.

Leave a Reply

Innospec - Is it time to Sell?

Top Brokerage Firms are advising their investors on Innospec. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.